Canada March 23, 2012 Special Alert – Caffeinated Energy Drinks FOR IMMEDIATE RELEASE As per previous communication from Health Canada, caffeinated energy drinks will no longer be considered NHPs. They […] Read More >>
By: Ashleigh Hampton, MSc, Manager Scientific Affairs March 19, 2012 The Natural Health Products Directorate (NHPD) released the Evidence for Safety and Efficacy of Finished Natural Health Products (NHPs) guidance […] Read More >>
By William Morkel, BSc Director of Quality & Compliance March 12, 2012 On January 30, 2012, dicentra posted an article on our website entitled Health Canada’s Interim Notification Program for […] Read More >>
By: Manushvi Chadha, BPharm, RA Cert NHP, Cosmetic and Drug Regulatory Affairs Associate March 5, 2012 Project # 1663 is Health Canada’s new initiative for the purpose of adding certain […] Read More >>
By Ryan Ramdeo, International Regulatory Affairs Associate February 27, 2012 As of February 17, 2012 USDA has announced revisions to the requirements for the export of meat products to the […] Read More >>
FOR IMMEDIATE RELEASEProposal to amend the Food and Drug Regulations -(addition of pancrelipase, pancreatin and pancreatic enzymes) – Project 1663 – Schedule F Amendment In November 2011, the NHPD (rather […] Read More >>
By: David Miller, BSc, N.D., NHP Scientific Regulatory Associate February 21, 2011 The recent revisions to the status of Levocarnitine in the Canadian regulatory environment (http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/html/sor-dors275-eng.html) have Read More >>
By: Rupika Malhotra, MSc – Food, Scientific and Regulatory Affairs Associate February 13, 2012 With the introduction of any new set of guidelines, regulations or changes impacting any sector of […] Read More >>
By William Morkel, Director of Quality & Compliance February 7, 2012 Sometime in early 2010 the Natural Health Products Directorate (NHPD) decided to halt reviews of all product licence applications […] Read More >>
By: Arwen Brooks – Quality Assurance and Regulatory Affairs Assistant February 6, 2012 BSE – a crisis in Europe and worldwide In the past two decades, Bovine Spongiform Encephalopathy (BSE) […] Read More >>
By: Clara Di Tella, BSc, Pharm QA – Regulatory Affairs Specialist January 30, 2012 Last spring, Health Canada consulted with stakeholders and the public on various options for policies for […] Read More >>
By: Ashleigh Hampton, MSc, Scientific & Regulatory Affairs Associate January 23, 2012 You’ve developed an innovative natural health product, compiled the full submission for a Product License Application and thought […] Read More >>
Health Canada Allows for OTC Use of 10 Naturally Sourced Ingedients An excerpt from the American Herbal Products Association Report by Anne Wilkie, Senior Regulatory Strategy and Policy Advisor dicentra Read More >>
by Manushvi Chadha, BPharm, RA Cert Regulatory Affairs Associate, dicentra The past year had the NHPD re-evaluate their strategy for enzyme and probiotic-containing products, which had been on hold for […] Read More >>
William Morkel, BSc Director of Quality and Compliance, dicentra If, based on my years of experience, I had to list the primary root causes for non-conformances in GMP regulated facilities, […] Read More >>
dicentra is proud to announce the launch of GMP Online Training for Natural Health Products beginning November 2011. For years, dicentra has been delivering on-site and off-site GMP training programs, […] Read More >>
By Arwen Brooks Quality Assurance and Regulatory Affairs Assistant, dicentra Dec. 15, 2010 — The FDA today announced new steps to target harmful products marketed as dietary supplements, including the […] Read More >>